Old Web
PDG80 Healthcare Resource Utilization and Costs for Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI